Literature DB >> 3292706

Differences between vascular and plaque core amyloid in Alzheimer's disease.

F Prelli1, E Castaño, G G Glenner, B Frangione.   

Abstract

The predominant protein of cerebrovascular and plaque core amyloid in Alzheimer's disease, Down's syndrome, hereditary hemorrhage with amyloidosis--Dutch type, sporadic cerebral amyloid angiopathy, and age-related amyloidosis is a unique polypeptide, called beta protein. The length of the plaque amyloid protein was reported to be 42-43 residues, but the complete length of the cerebral vascular amyloid is not known. To clarify this issue, amyloid fibrils from the leptomeninges of an Alzheimer's disease patient were isolated and the primary structure determined. The complete sequence of cerebrovascular beta-amyloid protein, although homologous to the plaque core amyloid protein previously reported, has 39 residues instead of 42. Amino terminal heterogeneity is present but minimal, and it is three residues shorter at the carboxy terminus. These differences are similar to those found in two cases of hereditary hemorrhage with amyloidosis--Dutch type. The differences between vascular and plaque beta-amyloid may reflect diverse processing of the beta protein precursor in the vessel wall and brain parenchyma due to tissue-specific endopeptidases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292706     DOI: 10.1111/j.1471-4159.1988.tb01087.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  88 in total

1.  Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

Authors:  J Van Dorpe; L Smeijers; I Dewachter; D Nuyens; K Spittaels; C Van Den Haute; M Mercken; D Moechars; I Laenen; C Kuiperi; K Bruynseels; I Tesseur; R Loos; H Vanderstichele; F Checler; R Sciot; F Van Leuven
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Amyloid in the brains of aged squirrel monkeys.

Authors:  L C Walker; C Masters; K Beyreuther; D L Price
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Epitope map of two polyclonal antibodies that recognize amyloid lesions in patients with Alzheimer's disease.

Authors:  J Ghiso; T Wisniewski; R Vidal; A Rostagno; B Frangione
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

4.  Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.

Authors:  S A Frautschy; G M Cole; A Baird
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

Review 5.  Current status review: cerebral amyloid.

Authors:  L W Duchen
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

Review 6.  Amyloidosis in aging and Alzheimer's disease.

Authors:  D L Price; L C Walker; L J Martin; S S Sisodia
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

7.  Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.

Authors:  J M Pasternack; C R Abraham; B J Van Dyke; H Potter; S G Younkin
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

8.  Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.

Authors:  Xudong Huang; Craig S Atwood; Robert D Moir; Mariana A Hartshorn; Rudolph E Tanzi; Ashley I Bush
Journal:  J Biol Inorg Chem       Date:  2004-11-03       Impact factor: 3.358

Review 9.  Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.

Authors:  A J Rozemuller; R A Roos; G T Bots; W Kamphorst; P Eikelenboom; W E Van Nostrand
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 10.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.